0.8740EUR-9.43%Mkt Cap: 78.64M EURP/E: —Last update: 2026-05-13
Nanoform Finland Oyj engages in the provision of nanotechnology and drug particle engineering services for the pharma and biotech industries in Europe and the United States. The company provides nanoforming technologies,…
Industry Peers
Biotechnologyloading…
Indicators:|
Key Statistics
Valuation
P/E (Trailing)—
P/E (Forward)-6.80
PEG—
P/B1.84
P/S15.66
EV/EBITDA-3.23
EV/Revenue12.09
EPS (TTM)-0.21
EPS (Forward)-0.14
Cash Flow & Leverage
FCF Yield-15.19%
FCF Margin-237.92%
Operating CF-17.66M EUR
CapEx (TTM)1.14M EUR
Net Debt/EBITDA0.95
Net Debt-17.79M EUR
Technical
SMA 500.5952 (+46.8%)
SMA 2000.8813 (-0.8%)
Beta0.56
S&P 52W Chg24.23%
Avg Vol (30d)393.78K
Avg Vol (10d)462.47K
Technical Indicators
RSI (14)71.4
MACD0.0569
MACD Signal0.0060
MACD Hist.+0.0510
BB Upper0.8482 EUR
BB Middle0.5772 EUR
BB Lower0.3062 EUR
BB Width93.90%
ATR (14)0.0833 EUR
Vol Ratio (20d)3.30x
52W Range
0.377049% of range1.382
52W High1.382 EUR
52W Low0.3770 EUR
Profitability
Gross Margin85.82%
EBITDA Margin0.00%
Profit Margin-504.74%
Oper. Margin-147.96%
ROE-41.84%
ROA-33.16%
Revenue Growth72.20%
Earnings Growth—
Balance Sheet
Debt/Equity0.15
Current Ratio4.32
Quick Ratio4.21
Book Value/Sh0.5000 EUR
Cash/Share0.2810 EUR
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 EUR
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Ownership
Shares Out.85.67M
Float24.58M
Insiders23.30%
Institutions40.38%
Analyst Consensus
Rating—
Target (Mean)2.625 EUR
Target Range2.000 EUR – 3.250 EUR
# Analysts2
Company
Market Cap78.64M EUR
Enterprise Value60.72M EUR
Revenue (TTM)5.02M EUR
Gross Profit3.04M EUR
Net Income (TTM)-17.90M EUR
Revenue/Share0.0590 EUR
Fiscal Year EndDec 2025
MR QuarterDec 2025
Employees171
Last Price0.8740 EUR
CountryFI
SectorHealthcare
IndustryBiotechnology
ISINFI4000330972